Skin Biopsy Market Report 2026

Skin Biopsy Market Overview

• Skin Biopsy market size has reached to $1.86 billion in 2025 • Expected to grow to $2.74 billion in 2030 at a compound annual growth rate (CAGR) of 8% • Growth Driver: Rising Healthcare Expenditure Fueling The Growth Of The Market Due To Improving Access To Advanced Diagnostics And Expand1g Dermatology Services • Market Trend: Advancements In Semi-Automatic Biopsy Instruments Drive Growth In Skin Biopsy Market • North America was the largest region in 2025.

What Is Covered Under Skin Biopsy Market?

A skin biopsy refers to a medical procedure in which a small sample of skin tissue is removed for diagnostic or research purposes. It is used to diagnose skin conditions, including infections, inflammatory disorders, and skin cancers, by analyzing the tissue’s cellular structure. It helps clinicians determine the nature, severity, and appropriate treatment for various skin abnormalities. The main types of skin biopsy are excisional biopsy, incisional biopsy, punch biopsy, shave biopsy, and needle biopsy. Excisional biopsy refers to a surgical procedure in which an entire lump, lesion, or suspicious area of tissue is completely removed along with a margin of normal surrounding tissue, primarily for diagnostic examination under a microscope. The various procedure types include surgical biopsy, image-guided biopsy, dermatoscopic biopsy, and endoscopic biopsy, and it finds application in dermatology, oncology, pathology, clinical research, and cosmetic procedures. The key end-users include hospitals, ambulatory surgical centers (ASCs), diagnostic laboratories, research institutions, and dermatology clinics.

What Is The Skin Biopsy Market Growth Forecast?

The skin biopsy market size is expected to see strong growth in the next few years. It will grow to $2.74 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to rising melanoma cases, AI-enabled diagnostics adoption, expansion of tele-dermatology, aging population, growth in cosmetic dermatology. Major trends in the forecast period include minimally invasive biopsy techniques, dermatology diagnostic expansion, punch and shave biopsy preference, outpatient diagnostic procedures, ai-assisted pathology integration.

Global Skin Biopsy Market Segmentation

1) By Type Of Biopsy: Excisional Biopsy, Incisional Biopsy, Punch Biopsy, Shave Biopsy 2) By Application: Dermatology, Oncology, Clinical Research 3) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Dermatology Clinics Subsegments: 1) By Excisional Biopsy: Full-Thickness Excision, Elliptical Excision 2) By Incisional Biopsy: Wedge Biopsy, Longitudinal Biopsy, Keyhole Biopsy 3) By Punch Biopsy: 2 Millimeter (mm) Punch, 3-4 Millimeter (mm) Punch, Greater Than Or Equal To (?) 5 Millimeter (mm) Punch 4) By Shave Biopsy: Tangential Shave, Saucerization Shave, Curved Blade Shave

What Is The Driver Of The Skin Biopsy Market?

The rising healthcare expenditure is expected to propel the growth of the skin biopsy market going forward. Healthcare expenditure refers to the total amount of money spent on medical services, treatments, facilities, research, and public health initiatives to maintain or improve health outcomes. The increasing demand for healthcare expenditure is due to the rising prevalence of chronic diseases, which require long-term and costly treatments. Rising healthcare expenditure enhances skin biopsy adoption by improving access to advanced diagnostic technologies and expanding dermatology services. It enables early detection and accurate diagnosis of skin disorders, supporting better patient outcomes and overall healthcare efficiency. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure saw a 5.6% increase in nominal terms in 2023, an increase of 0.9% growth compared to 2022. Therefore, the rising healthcare expenditure is driving the growth of the skin biopsy industry.

Key Players In The Global Skin Biopsy Market

Major companies operating in the skin biopsy market are AccuTec Inc., Delasco, KAI Medical, Medline Industries, Becton Dickinson and Company, Merit Medical Systems, Cook Medical, Hologic, Olympus Corporation, KARL STORZ, Richard Wolf, ConMed, Integra LifeSciences, Paramount Surgimed, Sklar Instruments, Hu-Friedy, Aesculap, World Precision Instruments, Miltex, Integra Miltex

Global Skin Biopsy Market Trends and Insights

Major companies operating in the skin biopsy market are focusing on developing advanced solutions such as semi-automatic biopsy instruments to enhance diagnostic accuracy and tissue sample quality. Semi-automatic biopsy instruments are designed to provide controlled and precise tissue collection, improving the likelihood of an accurate diagnosis and enabling pathologists to perform comprehensive testing. For instance, in May 2023, Argon Medical Devices, a US-based provider of interventional and oncology device solutions, launched the SuperCore Advantage Semi-Automatic Biopsy Instrument. The device delivers superior tissue volume and is available in a full range of lengths and gauge sizes to suit various clinical applications. It is disposable, next-generation, and designed with input from healthcare professionals to meet clinical needs. The SuperCore Advantage allows physicians to collect more tissue confidently, supports precise and reliable biopsies, and complements Argon’s existing portfolio, including the BioPince Ultra Full Core Biopsy Instrument, SuperCore Semi-Automatic, Tru-Core Automatic, and Pro-Mag Ultra Biopsy Instruments. This addition strengthens Argon’s position as a leading provider of soft tissue biopsy devices while enhancing outcomes for patients.

What Are Latest Mergers And Acquisitions In The Skin Biopsy Market?

In April 2023, Aurora Diagnostics LLC, a US-based provider of anatomic pathology and diagnostic laboratory services, acquired DermPath New England, LLC, for an undisclosed amount. With this acquisition, Aurora Diagnostics expanded its national dermatopathology network to strengthen diagnostic capabilities and enhance service coverage for physicians who rely on rapid and accurate skin biopsy interpretation. DermPath New England is a US-based dermatopathology laboratory that offers comprehensive diagnostic evaluation of skin biopsy specimens for referring clinicians.

Regional Outlook

North America was the largest region in the skin biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Skin Biopsy Market?

The skin biopsy market includes revenues earned by entities through skin tissue collection procedures, histopathological examination, molecular and immunohistochemistry testing, diagnostic pathology reporting services, and follow-up consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.